Testing a new stomach ulcer medication
Treatments studied
Part of Digestive system clinical trials.
This trial tests a new medication (DWP14012) for people with stomach (gastric) ulcers. It aims to see if the drug helps ulcers heal better than a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have at least one stomach ulcer that is between 3 mm and 30 mm in size.
- Your ulcer must be in a specific active or early healing stage (called A1 or A2 by your doctor).
- You cannot have active bleeding, a blocked stomach, or certain other serious stomach conditions.
- You cannot have had cancer (especially stomach cancer) in the last 5 years.
- You cannot have pancreatitis or inflammatory bowel disease (like Crohn's or ulcerative colitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medications, esomeprazole and sucralfate, to see if they help heal stomach ulcers after an endoscopic procedure (ESD) for early stomach cancer or pre-cancerous growths. It may help you if you need this procedure and have a larger ulcer afterwards.
This trial tests a new drug (AD-115A or AD-1151) in healthy volunteers to see how safe it is and how the body processes it. If you qualify, you'll receive a single dose and be monitored closely.
This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.
This study tests whether a medication called fexuprazan can protect your stomach from ulcers while you take NSAIDs (common pain relievers like ibuprofen) for ongoing joint or muscle problems. The trial checks if it's safe and works better than standard care.
This study tests a new medicine called Ilaprazole 10 mg to see if it can prevent stomach ulcers caused by NSAIDs (pain relievers like ibuprofen). If you take NSAIDs regularly and have a higher risk of ulcers, this trial may help protect your stomach.
This trial tests if a new stomach acid medicine (Zastaprazan) affects how well clopidogrel works in heart patients who have had a stent placed. It aims to help people who need both clopidogrel and a stomach acid drug after a procedure.
Hear when a new Gastric Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.